UNDERWRITING AGREEMENT between GLAXOSMITHKLINE PLC as Issuer and as Representatives of the Underwriters Dated as of [ ], 20[ ]Underwriting Agreement • April 3rd, 2017 • Glaxosmithkline Capital PLC • Pharmaceutical preparations • New York
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
ContractIndenture • April 3rd, 2017 • Glaxosmithkline Capital PLC • Pharmaceutical preparations • New York
SECOND SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital Inc., a corporation organized under the laws of the State of Delaware (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).
ContractFirst Supplemental Indenture • April 3rd, 2017 • Glaxosmithkline Capital PLC • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, among GlaxoSmithKline Capital plc, a public limited company incorporated under the laws of England and Wales (the “Company”), GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales, as guarantor (the “Guarantor”), and Law Debenture Trust Company of New York (as successor to Citibank, N.A.), a company duly organized and existing under the laws of the State of New York (the “Trustee”).
ContractFirst Supplemental Indenture • April 3rd, 2017 • Glaxosmithkline Capital PLC • Pharmaceutical preparations • New York
FIRST SUPPLEMENTAL INDENTURE dated as of March 21, 2014, between GlaxoSmithKline plc, a public limited company incorporated under the laws of England and Wales (the “Company”) and Law Debenture Trust Company of New York, a company duly organized and existing under the laws of the State of New York (the “Trustee”).
